ECO Animal Health Group plc (FRA:LWA)

Market Cap	69.74M +10.8%
Revenue (ttm)	100.24M +10.0%
Net Income	2.51M +29.9%
EPS	0.04 +29.6%
Shares Out	n/a
PE Ratio	27.81
Forward PE	19.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.9650
Previous Close	0.9900
Day's Range	0.9650 - 0.9900
52-Week Range	0.8050 - 1.4100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 15, 2026

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 200
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LWA

Financial Performance

In fiscal year 2026, ECO Animal Health Group's revenue was 87.53 million, an increase of 9.96% compared to the previous year's 79.60 million. Earnings were 2.19 million, an increase of 29.89%.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 21, 2026

Data Sources Report a data error